← All trials
NCT05268198
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 24, 2023
- Primary completion
- Jun 30, 2023
- Completion date
- Jul 14, 2023
- First posted
- Mar 7, 2022
- Last posted
- Dec 15, 2022
- Enrollment
- 48
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Global Health Drug Discovery InstituteLead sponsor
- Avance Clinical Pty Ltd.Collaborator
- Global Health Drug Discovery InstituteStudy director
- Global Health Drug Discovery InstituteOfficial
- CMAX Clinical ResearchCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.